Volv Global finds more patients with AI—uncovering hidden populations to speed diagnosis, support trials, and improve healthcare.
The idea that an AI system could detect a disease that appears nowhere in a patient's medical record sounds like…
Introduction Advocacy plays a critical role in accelerating progress in rare diseases. As technology advances, collaboration between patient communities, researchers,…
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction Earlier cancer detection remains one of the most powerful opportunities…
Finding the Patients We're Missing Rare diseases often remain undiagnosed for years, leaving patients without timely treatment and care. Despite…
In 2024, Sanofi – working in partnership with The BMJ – released the Rairity: Air Time For Rare Diseases podcast…
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: COPD as a “Syndrome,” Not Just One Disease Chronic…
“The patient voice” is shorthand for patients’ and caregivers’ lived experience—captured in a way that can inform decisions. In other…
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: The Urgency of Early Diagnosis in Type 1 Diabetes…
Introduction Artificial intelligence continues to push healthcare into a new era from early disease detection to large-scale data modelling. Yet…
How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: A case study in alpha-1 antitrypsin deficiency…